Cervical Cancer

Latest News

Tisotumab Vedotin Earns Japanese Approval in Advanced Cervical Cancer

March 28th 2025

Tisotumab vedotin elicited a median OS of 11.5 months vs 9.5 months with chemotherapy in advanced cervical cancer in the phase 3 innovaTV 301 trial.

Increased incidence and mortality rates for cervical cancer among rural women in the US may result from barriers to access to care.

Women in Rural Regions Experience Greater Cervical Cancer Incidence/Mortality

By Roman Fabbricatore

March 25th 2025

Patients who had recurrence in the radiation field experienced similar responses vs those with recurrence outside the radiation field.

Immunotherapy Sustains Responses in Radiated Endometrial/Cervical Cancer

By Roman Fabbricatore

March 18th 2025

Despite all groups completing chemoradiation within 56 days, delays contributed to a nonsignificant difference in length between Black vs White patients.

Increased Wait Times Observed for Black/Hispanic Patients With Cervical Cancer

By Roman Fabbricatore

March 18th 2025

Cancer Vaccine/Durvalumab Yields Efficacy in HPV+ Cervical Cancer

By Ashling Wahner

March 16th 2025

Latest CME Events & Activities

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Epithelioid Sarcoma: Applying Clinical Updates to Real Patient Cases

Collaborating Across the Continuum®: Identifying and Treating Epithelioid Sarcoma

Mastering Epithelioid Sarcoma: Enhancing Diagnostic Precision and Tailoring Treatment Strategies

Clinical Showcase™: Selecting the Best Next Steps for a Patient with Epithelioid Sarcoma

More News

Commentary (Zweizig)-Human Papillomaviruses: Their Clinical Significance in the Management of Cervical Carcinoma

Susan Zweizig, MD

April 1st 1995

Hines and colleagues provide a comprehensive review of the human papillomavirus (HPV) and its association with cervical carcinoma. It is now widely appreciated that HPV infection is important in the etiology of cervical dysplasia and carcinoma.

Commentary (Sedlis)-Human Papillomaviruses: Their Clinical Significance in the Management of Cervical Carcinoma

Alexander Sedlis, MD

April 1st 1995

Cervical cancer, which has claimed over 4,500 deaths annually in the United States and hundreds of thousands of lives in other parts of the world, is a preventable disease. Most cervical cancers are preceded by a prolonged phase of cervical

Human Papillomaviruses: Their Clinical Significance in the Management of Cervical Carcinoma

Jeffrey F. Hines, MD;A. Bennett Jenson, MD;Willard A. Barnes, MD

April 1st 1995

Studies have shown a strong association between certain human papillomaviruses and the development of cervical carcinoma and its precursor lesions. The oncogenic potential of papillomaviruses has been clearly

...

8 9 10 11 12